1. Xie, Yang, Li, Jun, Tao, Qing, Zeng, Chunyan, Chen, Youxiang. 2024. Identification of glutamine metabolism-related gene signature to predict colorectal cancer prognosis. In Journal of Cancer, 15, 3199-3214. doi:10.7150/jca.91687. https://pubmed.ncbi.nlm.nih.gov/38706895/
2. Wang, Nana, Cao, Shuming, Tan, Xiaofeng, Liu, Meirong. 2025. Significance of LRFN4 in prognosis and tumor microenvironment of lung adenocarcinoma. In Frontiers in pharmacology, 16, 1540636. doi:10.3389/fphar.2025.1540636. https://pubmed.ncbi.nlm.nih.gov/40070576/
3. Han, Songling, Zhu, Wei, Yang, Weili, Hu, Xingjiang, Tian, Jingkui. 2021. A Prognostic Signature Constructed by CTHRC1 and LRFN4 in Stomach Adenocarcinoma. In Frontiers in genetics, 12, 646818. doi:10.3389/fgene.2021.646818. https://pubmed.ncbi.nlm.nih.gov/34512711/
4. Gu, Yan-Hui, Wang, Jing, Lu, Wei-Cheng, Luo, Su-Xia, Xin, Wen-Jun. 2023. POU2F1/DNMT3a Pathway Participates in Neuropathic Pain by Hypermethylation-Mediated LRFN4 Downregulation Following Oxaliplatin Treatment. In Neurochemical research, 48, 3652-3664. doi:10.1007/s11064-023-04011-w. https://pubmed.ncbi.nlm.nih.gov/37592110/
5. Huang, Shaohua, Ma, Liping, Lan, Biyang, Nong, Wenwei, Huang, Zhihu. 2021. Comprehensive analysis of prognostic genes in gastric cancer. In Aging, 13, 23637-23651. doi:10.18632/aging.203638. https://pubmed.ncbi.nlm.nih.gov/34686626/
6. Li, Huiqin, Li, Ming, Tang, Chunhui, Xu, Liang. . Screening and prognostic value of potential biomarkers for ovarian cancer. In Annals of translational medicine, 9, 1007. doi:10.21037/atm-21-2627. https://pubmed.ncbi.nlm.nih.gov/34277807/
7. Morimura, Naoko, Inoue, Takashi, Katayama, Kei-ichi, Aruga, Jun. 2006. Comparative analysis of structure, expression and PSD95-binding capacity of Lrfn, a novel family of neuronal transmembrane proteins. In Gene, 380, 72-83. doi:. https://pubmed.ncbi.nlm.nih.gov/16828986/
智鼠故事 
